All In Biotech

Drug Trial Radar · NCT07640984

A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)

A Global, Open-Label, Phase I/II Trial, to Evaluate Safety, Tolerability, Pharmacodynamic and Preliminary Efficacy of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

Sep 9, 2026

Primary completion

Jun 30, 2028

Study completion Sep 30, 2028

Sponsor

Lead sponsor
JCR Pharmaceuticals Co., Ltd.Industry
Sponsor type
Industry
Collaborators
MEDIPAL HOLDINGS CORPORATION
First posted
Jun 11, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, up to 5 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a global, open-label, Phase I/II, interventional trial in participants younger than 6 years of age with Mucopolysaccharidosis Type IIIB (MPS IIIB), designed to assess the safety and tolerability of JR-446, determine its pharmacodynamic effects, and explore its potential to demonstrate early clinical effects on disease-relevant outcomes.

Conditions

  • Mucopolysaccharidosis IIIB

Interventions

  • JR-446Drug

    IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To establish the safety and tolerability of JR-446 in MPS IIIB patients following repeated dose administrationTime frame: Up to 1 year (multiple visits)

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • Children's Hospital Oakland Research Institution, Attn: 2900 Wing

    Oakland, California · Recruiting

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania · Not yet recruiting

  • Lysosomal and Rare Disorders Research and Treatment Center (LDRTC)

    Fairfax, Virginia · Not yet recruiting

  • University Medical Center Hamburg-Eppendorf

    Hamburg, Germany · Not yet recruiting

  • Great Ormond Street Hospital for Children

    London, United Kingdom · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.